Manufacturing News of Note—Biocon Bengaluru plant gets FDA nod; Samsung, Ichnos Sciences expand agreement

stocks
(Pixabay)

> The FDA has issued an Establishment Inspection Report concluding its investigation of Biocon’s biosimilar plant in Bengaluru, India. Filing (PDF)

> Samsung Biologics has won a long-term manufacturing agreement to produce a treatment for moderate-to-severe atopic dermatitis from Ichnos Sciences if it is approved. Release

> Pharma Logistics has acquired the pharma returns business of competitor Stericycle. Release

> Heraeus Pharmaceutical Ingredients is adding capacity to its plant in Hanau, Germany, to make platinum-based HPAPIs used in cancer chemotherapies Story

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

> Ingredient distributor Barentz has acquired a majority shareholding in ingredient maker IMCoPharma, which is based in Czech Republic. Release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.